Bellevue Group Ag Edwards Lifesciences Corp Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bellevue Group Ag holds 1,134,076 shares of EW stock, worth $85.5 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

1,134,076

Previous 1,260,461 10.03%

Holding current value

$85.5 Million

Previous $116 Million 35.72%

% of portfolio

1.26%

Previous 1.95%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $7.55 Million - $11.9 Million	-126,385 Reduced 10.03%	1,134,076 $74.8 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $13.3 Million - $14.8 Million	157,325 Added 14.26%	1,260,461 $116 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $6.1 Million - $8.04 Million	84,138 Added 8.26%	1,103,136 $105 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $398,584 - $502,251	-6,459 Reduced 0.63%	1,018,998 $77.7 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $875,352 - $1.18 Million	-12,635 Reduced 1.22%	1,025,457 $71 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $209,793 - $243,088	-2,577 Reduced 0.25%	1,038,092 $97.9 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $1.74 Million - $1.98 Million	-23,462 Reduced 2.2%	1,040,669 $86.1 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $2.62 Million - $3.36 Million	38,416 Added 3.75%	1,064,131 $79.4 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.24 Million - $1.62 Million	15,088 Added 1.49%	1,025,715 $84.8 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $8.46 Million - $12.6 Million	97,842 Added 10.72%	1,010,627 $96.1 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $856,464 - $1.08 Million	-8,400 Reduced 0.91%	912,785 $107 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $5.45 Million - $6.7 Million	51,234 Added 5.89%	921,185 $119 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $2.09 Million - $2.49 Million	-20,305 Reduced 2.28%	869,951 $98.5 Million
Q1 2021 May 12, 2021	BUY	$78.68 - $90.67 $4.98 Million - $5.74 Million	63,338 Added 7.66%	890,256 $74.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $64,521 - $82,107	-900 Reduced 0.11%	826,918 $75.4 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $2.43 Million - $3.16 Million	36,136 Added 4.56%	827,818 $66.1 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $32.1 Million - $42.9 Million	557,717 Added 238.38%	791,682 $54.7 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $1.64 Million - $2.53 Million	31,222 Added 15.4%	233,965 $44.1 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $595,898 - $682,249	8,311 Added 4.27%	202,743 $47.3 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $1.26 Million - $1.54 Million	20,466 Added 11.76%	194,432 $42.8 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $671,889 - $776,398	12,054 Added 7.44%	173,966 $32.1 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $197,067 - $263,565	4,115 Added 2.61%	161,912 $31 Million
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $4.43 Million - $5.44 Million	-95,536 Reduced 37.71%	157,797 $24.2 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $2.18 Million - $2.77 Million	47,673 Added 23.18%	253,333 $44.1 Million
Q2 2018 Aug 07, 2018	BUY	$42.45 - $51.3 $360,825 - $436,050	8,500 Added 4.31%	205,660 $29.9 Million
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $333,222 - $425,152	8,960 Added 4.76%	197,160 $27.5 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $596,731 - $695,627	-17,660 Reduced 8.58%	188,200 $21.2 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $579,188 - $619,726	15,960 Added 8.4%	205,860 $22.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	189,900	189,900 $22.5 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Edwards Lifesciences Corp Transaction History